The Food and Drug Administration has approved the first vaccine for expectant mothers to shield their babies from RSV.
Dr. Eric Simoes, from the Children's Hospital Colorado, worked with Pfizer and has been working on RSV prevention for decades. He calls this approval fantastic news.
, the newsletter by Dr. Caitlin Rivers, an epidemiologist at the Johns Hopkins Bloomberg School of Public Health.
France Dernières Nouvelles, France Actualités
Similar News:Vous pouvez également lire des articles d'actualité similaires à celui-ci que nous avons collectés auprès d'autres sources d'information.
US FDA approves Pfizer's maternal RSV vaccine to protect infantsThe U.S. Food and Drug Administration on Monday approved Pfizer's respiratory syncytial virus (RSV) vaccine for use in women during the middle of the third trimester of pregnancy to protect their babies.
Lire la suite »
FDA approves Pfizer maternal RSV vaccine for infantsPfizer hopes that its respiratory syncytial virus vaccine will be available to the public by the end of October or the beginning of November.
Lire la suite »
Pfizer maternal RSV vaccine gets FDA approvalNew shot designed to protect babies against leading cause of hospitalization is expected to be available this fall.
Lire la suite »
Pfizer's RSV vaccine to protect babies gets greenlight from FDAThe Food and Drug Administration has approved the first vaccine for expectant mothers to shield their babies from RSV.
Lire la suite »
FDA approves first maternal vaccine to prevent RSV, Pfizer's single-dose AbrysvoThe Food and Drug Administration (FDA) has approved the first vaccine for pregnant women to prevent RSV in infants, the agency announced on Monday. Abrysvo is made by Pfizer.
Lire la suite »